167 related articles for article (PubMed ID: 10088639)
1. Apoptosis and polycythemia vera.
Fernández-Luna JL
Curr Opin Hematol; 1999 Mar; 6(2):94-9. PubMed ID: 10088639
[TBL] [Abstract][Full Text] [Related]
2. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.
Silva M; Richard C; Benito A; Sanz C; Olalla I; Fernández-Luna JL
N Engl J Med; 1998 Feb; 338(9):564-71. PubMed ID: 9475763
[TBL] [Abstract][Full Text] [Related]
3. Defective expression of the SHP-1 phosphatase in polycythemia vera.
Wickrema A; Chen F; Namin F; Yi T; Ahmad S; Uddin S; Chen YH; Feldman L; Stock W; Hoffman R; Platanias LC
Exp Hematol; 1999 Jul; 27(7):1124-32. PubMed ID: 10390187
[TBL] [Abstract][Full Text] [Related]
4. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.
Fisher MJ; Prchal JF; Prchal JT; D'Andrea AD
Blood; 1994 Sep; 84(6):1982-91. PubMed ID: 8081000
[TBL] [Abstract][Full Text] [Related]
5. In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele.
Gaikwad A; Nussenzveig R; Liu E; Gottshalk S; Chang K; Prchal JT
Exp Hematol; 2007 Apr; 35(4):587-95. PubMed ID: 17379069
[TBL] [Abstract][Full Text] [Related]
6. Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera.
Dai CH; Krantz SB; Sawyer ST
Blood; 1997 May; 89(10):3574-81. PubMed ID: 9160662
[TBL] [Abstract][Full Text] [Related]
7. Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia.
Sokol L; Prchal JF; D'Andrea A; Rado TA; Prchal JT
Exp Hematol; 1994 May; 22(5):447-53. PubMed ID: 8174675
[TBL] [Abstract][Full Text] [Related]
8. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
9. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation.
Bruchova H; Yoon D; Agarwal AM; Swierczek S; Prchal JT
Blood Cells Mol Dis; 2009; 43(1):81-7. PubMed ID: 19264517
[TBL] [Abstract][Full Text] [Related]
10. MLF1IP promotes normal erythroid proliferation and is involved in the pathogenesis of polycythemia vera.
Feng G; Zhang T; Liu J; Ma X; Li B; Yang L; Zhang Y; Xu Z; Qin T; Zhou J; Huang G; Shi L; Xiao Z
FEBS Lett; 2017 Mar; 591(5):760-773. PubMed ID: 28173615
[TBL] [Abstract][Full Text] [Related]
11. Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia.
Florensa L; Besses C; Almarcha J; Lafuente R; Palou L; Pedro C; Sans-Sabrafen J; Woessner S
Eur J Haematol; 1989 Nov; 43(5):417-22. PubMed ID: 2693129
[TBL] [Abstract][Full Text] [Related]
12. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.
Ugo V; Marzac C; Teyssandier I; Larbret F; Lécluse Y; Debili N; Vainchenker W; Casadevall N
Exp Hematol; 2004 Feb; 32(2):179-87. PubMed ID: 15102479
[TBL] [Abstract][Full Text] [Related]
13. [Effect of bloodletting on the proliferative activity of erythroid progenitor cells from the bone marrow of patients with polycythemia and polycythemia vera].
Hansz J; Kozłowska-Skrzypczak M
Pol Arch Med Wewn; 1991 Sep; 86(3):125-31. PubMed ID: 1808597
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum.
Muller EW; de Wolf JT; Hendriks DW; Esselink MT; Halie MR; Vellenga E
Exp Hematol; 1993 Sep; 21(10):1353-7. PubMed ID: 7689483
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia.
Dobo I; Mossuz P; Campos L; Girodon F; Allégraud A; Latger-Cannard V; Boiret N; Pineau D; Wunder E; Zandecki M; Praloran V; Hermouet S
Hematol J; 2001; 2(6):396-403. PubMed ID: 11920280
[TBL] [Abstract][Full Text] [Related]
17. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.
Le Gall C; Ianotto JC; Hardy E; Ugo V; Eveillard JR; Ngo-Sack F; Bourquard P; Morice P; Berthou C
Leuk Res; 2008 May; 32(5):743-54. PubMed ID: 17980427
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of erythroid progenitors culture in polycythemia vera.
Najman A
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):177-8. PubMed ID: 8036137
[No Abstract] [Full Text] [Related]
20. Erythroid progenitors in polycythemia vera.
Varet B; Casadevall N; Lacombe C
Blood Cells; 1981; 7(1):125-32. PubMed ID: 7187745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
